| http://dbpedia.org/ontology/abstract
|
Kissei Pharmaceutical is a pharmaceutical … Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. and other Asian countries, but not China.
, キッセイ薬品工業株式会社（キッセイやくひんこうぎょう）は、長野県松本市芳野に本社を置く医薬品メーカーである。
|
| http://dbpedia.org/ontology/foundingDate
|
"1946-08-09"^^xsd:date
|
| http://dbpedia.org/ontology/foundingYear
|
1946
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_Executive_Officer +
|
| http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/Matsumoto%2C_Nagano +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
1504
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.kissei.co.jp/e_contents/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
62730357
|
| http://dbpedia.org/ontology/wikiPageLength
|
2056
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1036200361
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Silodosin +
, http://dbpedia.org/resource/Difelikefalin +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Japan +
, http://dbpedia.org/resource/Mitiglinide +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Matsumoto%2C_Nagano +
, http://dbpedia.org/resource/Fostamatinib +
, http://dbpedia.org/resource/Tranilast +
, http://dbpedia.org/resource/Linzagolix +
, http://dbpedia.org/resource/Remogliflozin_etabonate +
, http://dbpedia.org/resource/Category:Companies_based_in_Nagano_Prefecture +
|
| http://dbpedia.org/property/founded
|
"1946-08-09"^^xsd:date
|
| http://dbpedia.org/property/hqLocationCity
|
http://dbpedia.org/resource/Matsumoto%2C_Nagano +
|
| http://dbpedia.org/property/hqLocationCountry
|
Japan
|
| http://dbpedia.org/property/industry
|
Pharmaceutical products, therapeutic and care foods
|
| http://dbpedia.org/property/isin
|
JP3240600001
|
| http://dbpedia.org/property/keyPeople
|
Mutsuo Kanzawa
|
| http://dbpedia.org/property/name
|
Kissei Pharmaceutical
|
| http://dbpedia.org/property/numEmployees
|
1504
|
| http://dbpedia.org/property/website
|
https://www.kissei.co.jp/e_contents/ +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Company-stub +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Pharma-stub +
, http://dbpedia.org/resource/Template:Primary_sources +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Japan +
, http://dbpedia.org/resource/Category:Companies_based_in_Nagano_Prefecture +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Kissei?oldid=1036200361&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.kissei.co.jp/e_contents/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Kissei +
|
| http://xmlns.com/foaf/0.1/name
|
Kissei Pharmaceutical
|
| owl:sameAs |
http://dbpedia.org/resource/Kissei +
, http://bn.dbpedia.org/resource/%E0%A6%95%E0%A6%BF%E0%A6%B8%E0%A7%87%E0%A6%87_%E0%A6%AB%E0%A6%BE%E0%A6%B0%E0%A7%8D%E0%A6%AE%E0%A6%BE%E0%A6%B8%E0%A6%BF%E0%A6%89%E0%A6%9F%E0%A6%BF%E0%A6%95%E0%A6%BE%E0%A6%B2 +
, https://global.dbpedia.org/id/B7uQ +
, http://www.wikidata.org/entity/Q11296797 +
, http://ja.dbpedia.org/resource/%E3%82%AD%E3%83%83%E3%82%BB%E3%82%A4%E8%96%AC%E5%93%81%E5%B7%A5%E6%A5%AD +
, http://viaf.org/viaf/252977438 +
|
| rdf:type |
http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Agent +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
キッセイ薬品工業株式会社（キッセイやくひんこうぎょう）は、長野県松本市芳野に本社を置く医薬品メーカーである。
, Kissei Pharmaceutical is a pharmaceutical … Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. and other Asian countries, but not China.
|
| rdfs:label |
キッセイ薬品工業
, Kissei
|
